We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Belgian biopharmaceutical firm UCB has partnered with non-profit Epilepsy Society in the UK to provide targeted treatments for epilepsy patients whose seizures do not respond to existing therapies....